Petpal Pet Nutrition Technology Co., Ltd. (SHE:300673)
China · Delayed Price · Currency is CNY 15.22
-0.19 (-1.23%)
May 29, 2026, 3:04 PM CST
SHE:300673 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,460 | 1,438 | 1,645 | 1,400 | 1,726 | 1,267 |
Other Revenue | 10.4 | 10.4 | 13.68 | 11.46 | 5.56 | 3.75 |
| 1,471 | 1,449 | 1,659 | 1,411 | 1,732 | 1,271 | |
Revenue Growth (YoY) | -8.29% | -12.67% | 17.55% | -18.51% | 36.27% | -5.15% |
Cost of Revenue | 1,010 | 991.09 | 1,174 | 1,140 | 1,349 | 986.73 |
Gross Profit | 460.54 | 457.78 | 485.03 | 271.36 | 382.99 | 284.16 |
Selling, General & Admin | 251.35 | 251.29 | 232.57 | 211.56 | 205.28 | 157.33 |
Research & Development | 36.03 | 33.89 | 29.76 | 29.04 | 28.81 | 22.66 |
Other Operating Expenses | 6.36 | 5.87 | 5.26 | 5.27 | 4.33 | 4.19 |
Operating Expenses | 297.74 | 294.07 | 267.22 | 250.5 | 236.91 | 182.92 |
Operating Income | 162.79 | 163.71 | 217.8 | 20.86 | 146.08 | 101.24 |
Interest Expense | -29.02 | -28.74 | -20.4 | -20.51 | -21.66 | -8.43 |
Interest & Investment Income | 1.04 | 5.96 | 11.78 | 10 | 3.26 | 6.95 |
Currency Exchange Gain (Loss) | 5.46 | 5.46 | 18.58 | 8.15 | 52.84 | -22.57 |
Other Non Operating Income (Expenses) | -13.1 | -1.04 | -2.2 | -2.45 | -2.07 | -1.05 |
EBT Excluding Unusual Items | 127.18 | 145.35 | 225.56 | 16.06 | 178.44 | 76.15 |
Impairment of Goodwill | - | - | -2.15 | -4.37 | -1.54 | - |
Gain (Loss) on Sale of Investments | -2.31 | -2.64 | 0.99 | 0.12 | -10.75 | 0.4 |
Gain (Loss) on Sale of Assets | 0.28 | 0.48 | 0.02 | -9.95 | 0.06 | 0.12 |
Asset Writedown | -0.64 | -0.64 | -0.05 | -0.13 | -2.28 | -0.07 |
Other Unusual Items | 1.47 | 1.44 | -0.73 | 0.99 | 1.85 | 1.17 |
Pretax Income | 125.96 | 143.99 | 223.64 | 2.7 | 165.79 | 77.77 |
Income Tax Expense | 24.25 | 27.28 | 37.75 | 18.67 | 36.5 | 15.72 |
Earnings From Continuing Operations | 101.72 | 116.71 | 185.89 | -15.97 | 129.29 | 62.06 |
Minority Interest in Earnings | -0.21 | -1.04 | -3.68 | 4.88 | -2.16 | -2.04 |
Net Income | 101.51 | 115.67 | 182.21 | -11.09 | 127.12 | 60.02 |
Net Income to Common | 101.51 | 115.67 | 182.21 | -11.09 | 127.12 | 60.02 |
Net Income Growth | -37.62% | -36.52% | - | - | 111.81% | -47.73% |
Shares Outstanding (Basic) | 246 | 241 | 243 | 277 | 249 | 214 |
Shares Outstanding (Diluted) | 267 | 269 | 268 | 277 | 296 | 214 |
Shares Change (YoY) | -3.37% | 0.39% | -3.36% | -6.21% | 37.92% | -14.13% |
EPS (Basic) | 0.41 | 0.48 | 0.75 | -0.04 | 0.51 | 0.28 |
EPS (Diluted) | 0.38 | 0.43 | 0.68 | -0.04 | 0.43 | 0.28 |
EPS Growth | -35.44% | -36.77% | - | - | 53.57% | -39.13% |
Free Cash Flow | 117.39 | 121.09 | 239.7 | 36.49 | 74.4 | -245.88 |
Free Cash Flow Per Share | 0.44 | 0.45 | 0.90 | 0.13 | 0.25 | -1.15 |
Dividend Per Share | 0.250 | 0.250 | 0.350 | - | - | 0.030 |
Dividend Growth | -28.57% | -28.57% | - | - | - | -55.02% |
Gross Margin | 31.31% | 31.60% | 29.23% | 19.23% | 22.12% | 22.36% |
Operating Margin | 11.07% | 11.30% | 13.13% | 1.48% | 8.43% | 7.97% |
Profit Margin | 6.90% | 7.98% | 10.98% | -0.79% | 7.34% | 4.72% |
Free Cash Flow Margin | 7.98% | 8.36% | 14.45% | 2.58% | 4.30% | -19.35% |
EBITDA | 249.3 | 245.29 | 279.7 | 77.27 | 196.12 | 142.29 |
EBITDA Margin | 16.95% | 16.93% | 16.86% | 5.47% | 11.33% | 11.20% |
D&A For EBITDA | 86.5 | 81.58 | 61.89 | 56.4 | 50.05 | 41.04 |
EBIT | 162.79 | 163.71 | 217.8 | 20.86 | 146.08 | 101.24 |
EBIT Margin | 11.07% | 11.30% | 13.13% | 1.48% | 8.43% | 7.97% |
Effective Tax Rate | 19.25% | 18.95% | 16.88% | 690.78% | 22.02% | 20.21% |
Revenue as Reported | 1,471 | 1,449 | 1,659 | 1,411 | 1,732 | 1,271 |
Advertising Expenses | - | 63.08 | 62.5 | 53.94 | 43.68 | 23.74 |